After our report above, while several reports demonstrated that intracellular expression of CAPRIN-1 positively correlates with cancer progression and poor prognosis, suggesting that CAPRIN-1 could be a diagnostic biomarker and suitable cancer therapeutic target (18–25), we continued to focus on performing a detailed analysis of CAPRIN-1 expression on cancer cell membranes. This evidence concerns the gene CAPRIN1 and cancer.